These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30915718)

  • 21. Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage.
    Mink S; Muroi C; Seule M; Bjeljac M; Keller E
    Clin Neurol Neurosurg; 2011 Oct; 113(8):644-8. PubMed ID: 21703756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial.
    Malamiri RA; Ghaempanah M; Khosroshahi N; Nikkhah A; Bavarian B; Ashrafi MR
    Eur J Paediatr Neurol; 2012 Sep; 16(5):536-41. PubMed ID: 22326977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimal incidence of neurotoxicity without prophylaxis during busulfan-based conditioning regimen in patients undergoing stem cell transplantation.
    Leon-Rodriguez E; Rivera-Franco MM
    Int J Hematol; 2016 Dec; 104(6):644-646. PubMed ID: 27722893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levetiracetam Prophylaxis for Post-traumatic Brain Injury Seizures is Ineffective: A Propensity Score Analysis.
    Zangbar B; Khalil M; Gruessner A; Joseph B; Friese R; Kulvatunyou N; Wynne J; Latifi R; Rhee P; O'Keeffe T
    World J Surg; 2016 Nov; 40(11):2667-2672. PubMed ID: 27307089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretransplant conditioning in adults and children: dose assurance with intravenous busulfan.
    Fisher VL; Barnes YJ; Nuss SL
    Oncol Nurs Forum; 2006 Nov; 33(2):E36-43. PubMed ID: 16518436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levetiracetam for seizures after liver transplantation.
    Glass GA; Stankiewicz J; Mithoefer A; Freeman R; Bergethon PR
    Neurology; 2005 Mar; 64(6):1084-5. PubMed ID: 15781837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prophylactic efficacy of levetiracetam, valproate or phenobarbital on febrile convulsions in rats].
    Cheng M; Huang Z; Li SX
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jul; 12(7):573-5. PubMed ID: 20637159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limitations of oral busulfan in preparative regimen before hematopoietic stem-cell transplantation.
    Kami M; Hamaki T; Maruta Y; Miyakoshi S; Mutou Y
    Haematologica; 2002 Feb; 87(2):ELT10. PubMed ID: 11836187
    [No Abstract]   [Full Text] [Related]  

  • 29. Decreased Systemic Busulfan Exposure After Oral Dosing With Concomitant Levetiracetam Compared With Phenytoin.
    Artul T; Henig I; Nassar L; Yehudai-Ofir D; Scherb I; Lurie Y; Efrati E; Zuckerman T; Kurnik D
    Ther Drug Monit; 2022 Jun; 44(3):414-418. PubMed ID: 34739424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valproate therapy for prevention of posttraumatic seizures: a randomized trial.
    Temkin NR; Dikmen SS; Anderson GD; Wilensky AJ; Holmes MD; Cohen W; Newell DW; Nelson P; Awan A; Winn HR
    J Neurosurg; 1999 Oct; 91(4):593-600. PubMed ID: 10507380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversible Splenial Lesion Syndrome with Some Novel Causes and Clinical Manifestations.
    Lu PL; Hodes JF; Zheng X; Hu XY
    Intern Med; 2020 Oct; 59(20):2471-2480. PubMed ID: 32611957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Randomized Trial of Brief Versus Extended Seizure Prophylaxis After Aneurysmal Subarachnoid Hemorrhage.
    Human T; Diringer MN; Allen M; Zipfel GJ; Chicoine M; Dacey R; Dhar R
    Neurocrit Care; 2018 Apr; 28(2):169-174. PubMed ID: 28831717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers.
    Mawhinney E; Craig J; Morrow J; Russell A; Smithson WH; Parsons L; Morrison PJ; Liggan B; Irwin B; Delanty N; Hunt SJ
    Neurology; 2013 Jan; 80(4):400-5. PubMed ID: 23303847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Safety Outcomes of Undiluted Levetiracetam Intravenous Push Compared to Intravenous Piggyback.
    Shim A; Radparvar S; Davis N; Kaplan A; Kantaris K; Devlin A; Liang J; Ciummo F
    J Pharm Pract; 2024 Jun; 37(3):722-727. PubMed ID: 37231709
    [No Abstract]   [Full Text] [Related]  

  • 35. Protocol for seizure prophylaxis following intracerebral hemorrhage study (SPICH): a randomized, double-blind, placebo-controlled trial of short-term sodium valproate prophylaxis in patients with acute spontaneous supratentorial intracerebral hemorrhage.
    Hu X; Fang Y; Li H; Liu W; Lin S; Fu M; Li X; Cao X; Zhang H; You C; Liu M
    Int J Stroke; 2014 Aug; 9(6):814-7. PubMed ID: 24025111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levetiracetam as preventive treatment in adults with migraine: an up-to-date systematic review and quantitative meta-analysis.
    Tsaousi G; Pourzitaki C; Siafis S; Kyrgidis A; Grosomanidis V; Kouvelas D; Papazisis G
    Eur J Clin Pharmacol; 2020 Feb; 76(2):161-174. PubMed ID: 31768574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined valproate or carbamazepine and electroconvulsive therapy.
    Zarate CA; Tohen M; Baraibar G
    Ann Clin Psychiatry; 1997 Mar; 9(1):19-25. PubMed ID: 9167833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lorazepam for seizure prophylaxis during high-dose busulfan administration.
    Chan KW; Mullen CA; Worth LL; Choroszy M; Koontz S; Tran H; Slopis J
    Bone Marrow Transplant; 2002 Jun; 29(12):963-5. PubMed ID: 12098063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of intravenous site reactions in neurotrauma patients receiving valproate or phenytoin.
    Anderson GD; Lin Y; Temkin NR; Fischer JH; Winn HR
    Ann Pharmacother; 2000 Jun; 34(6):697-702. PubMed ID: 10860128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Busulfan use in hematopoietic stem cell transplantation: pharmacology, dose adjustment, safety and efficacy in adults and children.
    Krivoy N; Hoffer E; Lurie Y; Bentur Y; Rowe JM
    Curr Drug Saf; 2008 Jan; 3(1):60-6. PubMed ID: 18690982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.